Table 1 MASP2 gene polymorphism versus TB incidence.
TB patients (n = 503) | Controls (n = 494) | χ2 | P value | cOR (95%CI) | aOR (95%CI)a | |||
---|---|---|---|---|---|---|---|---|
n | % | n | % | |||||
rs12142107 | ||||||||
CC | 393 | 78.13 | 402 | 81.38 | 2.206 | 0.332 | 1 | 1 |
CT | 101 | 20.08 | 87 | 17.61 | 1.188 (0.863–1.633) | 1.167 (0.840–1.623) | ||
TT | 9 | 1.79 | 5 | 1.01 | 1.841 (0.612–5.543) | 1.465 (0.474–4.535) | ||
CT + TT | 110 | 21.87 | 92 | 18.62 | 1.223 (0.897–1.667) | 1.185 (0.860–1.633) | ||
rs12711521 | ||||||||
AA | 192 | 38.17 | 242 | 48.99 | 14.748 | 0.001 | 1 | 1 |
AC | 233 | 46.32 | 204 | 41.3 | 1.440 (1.102–1.880)* | 1.323 (1.004–1.743)* | ||
CC | 78 | 15.51 | 48 | 9.72 | 2.048 (1.364–3.075)* | 1.869 (1.227–2.847)* | ||
AC + CC | 311 | 61.83 | 252 | 50.75 | 1.556 (1.209–2.001)* | 1.423 (1.095–1.849)* | ||
rs7548659 | ||||||||
TT | 239 | 47.51 | 286 | 57.89 | 14.712 | 0.001 | 1 | 1 |
GT | 219 | 43.54 | 186 | 37.65 | 1.409 (1.086–1.828)* | 1.350 (1.029–1.772)* | ||
GG | 45 | 8.95 | 22 | 4.45 | 2.448 (1.429–4.192)* | 2.196 (1.263–3.817)* | ||
GT + GG | 264 | 52.49 | 208 | 42.11 | 1.519 (1.183–1.950)* | 1.439 (1.106–1.871)* |